Contact Congress about H.R. 5160: Stem Cell Therapeutic and Research Reauthorization Act of 2025

Patients who need stem cell or cord blood transplants could keep using the national matching system for five more years. The bill extends existing programs through 2031 and sets the main transplant program at $33,009,000 a year from 2027 to 2031.

Modern Action explains what the legislation does, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.

Stem Cell Therapeutic and Research Reauthorization Act of 2025 is a Senate bill waiting for floor action. The latest recorded action: Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464.

Latest action on H.R. 5160: Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 464.

Who this affects: This bill mainly affects people who need stem cell or cord blood transplants and the groups that help them get those cells. The biggest direct effect falls on patients searching for a match, along with hospitals, transplant centers, donors, and cord blood banks that take part in the national system. Researchers and public health programs tied to these efforts could also be affected because the bill keeps the current legal authority and funding structure in place.

Why this matters: This matters because some very sick patients depend on these programs to find transplant matches. If Congress did not extend the law, parts of the current system could lose federal authority or support after the dates in current law. The bill also raises the authorized funding for the main transplant program for future years, which could help the system keep operating as costs rise. But the bill does not say exactly how much real-world impact those funding levels would have.

Key provisions in H.R. 5160

• Keeps the C.W. Bill Young Cell Transplantation Program in place under the Public Health Service Act.
• Sets federal funding for the program at $33,009,000 a year for fiscal years 2027 through 2031.
• Keeps the older $31,009,000 amount for earlier years already written into law. It adds new years instead of rewriting the whole section.
• Extends the legal authority for the national cord blood inventory program from 2026 to 2031 by changing the end year in current law.
• Does not create a new program. It renews existing programs and updates their funding and dates under the 2005 Stem Cell Therapeutic and Research Act.

How Modern Action helps you take action on H.R. 5160

You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.

Questions people ask about H.R. 5160

What is H.R. 5160?

Patients who need stem cell or cord blood transplants could keep using the national matching system for five more years. The bill extends existing programs through 2031 and sets the main transplant program at $33,009,000 a year from 2027 to 2031.

How do I support or oppose H.R. 5160?

Choose support, oppose, or ask for changes on Modern Action. The action flow drafts the message for you and keeps the wording tied to this bill.

Who should I contact about H.R. 5160?

Modern Action uses your location to route the action to the congressional offices relevant to the bill and your representation.

How does Modern Action help me act on H.R. 5160?

Modern Action gives you bill-specific context, lets you choose support, opposition, or changes, and drafts a message from your position and reasons.